Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144170
Status:
COMPLETED
Last Update Posted:
2014-07-02
First Post:
2005-09-02
Brief Title:
TipranavirRitonavir vs Genotypically Defined Protease InhibitorRitonavir in HIV Patients RESIST-2
Sponsor:
Organization:
Boehringer Ingelheim